Year |
Citation |
Score |
2015 |
Agarwal P, Beahm BJ, Shieh P, Bertozzi CR. Systemic Fluorescence Imaging of Zebrafish Glycans with Bioorthogonal Chemistry. Angewandte Chemie (International Ed. in English). PMID 26230529 DOI: 10.1002/Anie.201504249 |
0.583 |
|
2015 |
Shieh P, Dien VT, Beahm BJ, Castellano JM, Wyss-Coray T, Bertozzi CR. CalFluors: A Universal Motif for Fluorogenic Azide Probes across the Visible Spectrum. Journal of the American Chemical Society. 137: 7145-51. PMID 25902190 DOI: 10.1021/Jacs.5B02383 |
0.56 |
|
2015 |
Kuhn J, Götting C, Beahm BJ, Bertozzi CR, Faust I, Kuzaj P, Knabbe C, Hendig D. Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum. Biochemical and Biophysical Research Communications. 459: 469-74. PMID 25748573 DOI: 10.1016/J.Bbrc.2015.02.129 |
0.434 |
|
2015 |
Beahm BJ, Bertozzi CR. Imaging cell surface glycans in animals with bioorthogonal chemistry Glycoscience: Biology and Medicine. 467-478. DOI: 10.1007/978-4-431-54841-6_109 |
0.496 |
|
2014 |
Beahm BJ, Dehnert KW, Derr NL, Kuhn J, Eberhart JK, Spillmann D, Amacher SL, Bertozzi CR. A visualizable chain-terminating inhibitor of glycosaminoglycan biosynthesis in developing zebrafish. Angewandte Chemie (International Ed. in English). 53: 3347-52. PMID 24554559 DOI: 10.1002/Anie.201310569 |
0.636 |
|
2012 |
Dehnert KW, Baskin JM, Laughlin ST, Beahm BJ, Naidu NN, Amacher SL, Bertozzi CR. Imaging the sialome during zebrafish development with copper-free click chemistry. Chembiochem : a European Journal of Chemical Biology. 13: 353-7. PMID 22262667 DOI: 10.1002/Cbic.201100649 |
0.556 |
|
2011 |
Dehnert KW, Beahm BJ, Huynh TT, Baskin JM, Laughlin ST, Wang W, Wu P, Amacher SL, Bertozzi CR. Metabolic labeling of fucosylated glycans in developing zebrafish. Acs Chemical Biology. 6: 547-52. PMID 21425872 DOI: 10.1021/Cb100284D |
0.56 |
|
Low-probability matches (unlikely to be authored by this person) |
2021 |
Mueller WF, Zhu L, Tan B, Dwight S, Beahm B, Wilsey M, Wechsler T, Mak J, Cowan T, Pritchett J, Taylor E, Crawford BE. GlcNAc-Asn (GNA) is a biomarker for NGLY1 deficiency. Journal of Biochemistry. PMID 34697629 DOI: 10.1093/jb/mvab111 |
0.163 |
|
2023 |
Tong S, Ventola P, Frater CH, Klotz J, Phillips JM, Muppidi S, Dwight SS, Mueller WF, Beahm BJ, Wilsey M, Lee KJ. NGLY1 deficiency: a prospective natural history study (NHS). Human Molecular Genetics. PMID 37379343 DOI: 10.1093/hmg/ddad106 |
0.118 |
|
2022 |
Zhu L, Tan B, Dwight SS, Beahm B, Wilsey M, Crawford BE, Schweighardt B, Cook JW, Wechsler T, Mueller WF. AAV9-NGLY1 gene replacement therapy improves phenotypic and biomarker endpoints in a rat model of NGLY1 Deficiency. Molecular Therapy. Methods & Clinical Development. 27: 259-271. PMID 36320418 DOI: 10.1016/j.omtm.2022.09.015 |
0.074 |
|
2008 |
He M, Beahm BJ, Bode JW. Chiral NHC-catalyzed oxodiene Diels-Alder reactions with α-chloroaldehyde bisulfite salts Organic Letters. 10: 3817-3820. PMID 18656948 DOI: 10.1021/Ol801502H |
0.07 |
|
Hide low-probability matches. |